Brief: Janux Therapeutics Q1 Basic EPS USD -0.38
08/05/2025 21:01
May 08 (Reuters) - Janux Therapeutics Q1 operating expenses USD 34.897 million. Q1 operating income USD -34.897 million Q1 net income USD -23.508 million
JANX — Janux Therapeutics News Story
0.000.00%
Last trade - 00:00- $1.04bn
- $72.08m
- $10.00m